🚀 VC round data is live in beta, check it out!
Pro-Dex Valuation Multiples
Discover revenue and EBITDA valuation multiples for Pro-Dex and similar public comparables like Vuno, Apyx Medical, SANUWAVE Health, Quanterix and more.
Pro-Dex Overview
About Pro-Dex
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
Founded
1994
HQ
Employees
181
Website
Financials (LTM)
EV
$173M
Pro-Dex Financials
Pro-Dex reported last 12-month revenue of $67M.
In the same LTM period, Pro-Dex generated $9M in net income.
Revenue (LTM)
Pro-Dex P&L
In the most recent fiscal year, Pro-Dex reported revenue of $67M and EBITDA of $14M.
Pro-Dex expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $67M | XXX | $67M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $20M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 29% | XXX | XXX | XXX |
| EBITDA | — | XXX | $14M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 21% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 16% | XXX | XXX | XXX |
| Net Profit | $9M | XXX | $9M | XXX | XXX | XXX |
| Net Margin | 13% | XXX | 13% | XXX | XXX | XXX |
| Net Debt | — | — | $15M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Pro-Dex Stock Performance
Pro-Dex has current market cap of $171M, and enterprise value of $173M.
Market Cap Evolution
Pro-Dex's stock price is $53.40.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $173M | $171M | 0.0% | XXX | XXX | XXX | $2.80 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPro-Dex Valuation Multiples
Pro-Dex trades at 2.6x EV/Revenue multiple, and 12.3x EV/EBITDA.
EV / Revenue (LTM)
Pro-Dex Financial Valuation Multiples
As of April 20, 2026, Pro-Dex has market cap of $171M and EV of $173M.
Equity research analysts estimate Pro-Dex's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Pro-Dex has a P/E ratio of 19.1x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $171M | XXX | $171M | XXX | XXX | XXX |
| EV (current) | $173M | XXX | $173M | XXX | XXX | XXX |
| EV/Revenue | 2.6x | XXX | 2.6x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 12.3x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 16.2x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 8.9x | XXX | XXX | XXX |
| P/E | 19.1x | XXX | 19.1x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (59.2x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Pro-Dex Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Pro-Dex Margins & Growth Rates
Pro-Dex's revenue in the last fiscal year grew by 11%.
Pro-Dex's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.0M for the same period.
Pro-Dex Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 11% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 21% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 53% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 7% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 5% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 13% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Pro-Dex Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Pro-Dex | XXX | XXX | XXX | XXX | XXX | XXX |
| Vuno | XXX | XXX | XXX | XXX | XXX | XXX |
| Apyx Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| SANUWAVE Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Quanterix | XXX | XXX | XXX | XXX | XXX | XXX |
| Owlet | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Pro-Dex M&A Activity
Pro-Dex acquired XXX companies to date.
Last acquisition by Pro-Dex was on XXXXXXXX, XXXXX. Pro-Dex acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Pro-Dex
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialPro-Dex Investment Activity
Pro-Dex invested in XXX companies to date.
Pro-Dex made its latest investment on XXXXXXXX, XXXXX. Pro-Dex invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Pro-Dex
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Pro-Dex
| When was Pro-Dex founded? | Pro-Dex was founded in 1994. |
| Where is Pro-Dex headquartered? | Pro-Dex is headquartered in United States. |
| How many employees does Pro-Dex have? | As of today, Pro-Dex has over 181 employees. |
| Who is the CEO of Pro-Dex? | Pro-Dex's CEO is Richard L. Van Kirk. |
| Is Pro-Dex publicly listed? | Yes, Pro-Dex is a public company listed on Nasdaq. |
| What is the stock symbol of Pro-Dex? | Pro-Dex trades under PDEX ticker. |
| When did Pro-Dex go public? | Pro-Dex went public in 1986. |
| Who are competitors of Pro-Dex? | Pro-Dex main competitors are Vuno, Apyx Medical, SANUWAVE Health, Quanterix. |
| What is the current market cap of Pro-Dex? | Pro-Dex's current market cap is $171M. |
| What is the current revenue of Pro-Dex? | Pro-Dex's last 12 months revenue is $67M. |
| What is the current EV/Revenue multiple of Pro-Dex? | Current revenue multiple of Pro-Dex is 2.6x. |
| Is Pro-Dex profitable? | Yes, Pro-Dex is net-income-positive (as of the last 12 months). |
| What is the current net income of Pro-Dex? | Pro-Dex's last 12 months net income is $9M. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.